Robert N. Hotchkiss, MD
Chief Innovation Officer, Medical Director of Clinical Research, Director of Research in the Hand & Upper Extremity Service, and Director of Translational and External Initiatives at HSS
Dr. Hotchkiss is the Chief Innovation Officer, Medical Director of Clinical Research, Director of Research in the Hand & Upper Extremity Service, and Director of Translational and External Initiatives at Hospital for Special Surgery. He specializes in the treatment of elbow injuries, hand and wrist injuries and arthritis, and vascular disorders of the hand. He was named as one of the "Best Doctors in New York," by New York magazine in 2009 and is a professor of orthopedic surgery at the Weill Cornell Medical College.
Selected innovation engagements: Recently, Dr. Hotchkiss developed a drug delivery platform that provides sustained, controlled local release of therapeutics to bones and joints spaces. This platform will ensure that the optimal dose of medication is delivered precisely to the location where it can be most effective. Dr. Hotchkiss and his team also recently developed a new prototype for an implant for use in total elbow replacement and special instrumentation that will improve both surgical techniques and implant longevity. He has also done clinical trials on the removal of volar plates after distal Radius fracture and treating carpometacarpal osteoarthritis.
Donna Rounds, PhD
Director, Technology Development
Donna joined HSS in February 2008 to lead their efforts in developing and commercializing orthopedic and rheumatology technologies. She brings with her a broad range of experience in business development, intellectual asset management, and technology transfer.
Prior to joining HSS, she spent five years at Columbia University’s Technology Ventures developing and commercializing healthcare related technologies, as well as championing start-up companies for a portfolio of scientists. Before Columbia, she was a business development executive at British Technology Group, BTG, plc, where she sourced, assessed and acquired early stage life and physical science technologies. She began her career in developing technology assets as a founder of Physiome Sciences, Inc., a biotechnology company that developed computational models of cells, tissues and organs.
She holds a PhD from Yale University in Molecular Biophysics and Biochemistry and a BA from the University of California at Berkeley.
Timothy Wright, PhD
Dr. Wright joined the Hospital for Special Surgery in 1976 and the Cornell University Medical College in 1978.
He is a recipient of honors for excellence in research from the Hip Society and the Knee Society and earned a Kappa Delta Award from the American Academy of Orthopaedic Surgeons. A past Whitaker Fellow and a past recipient of a Research Career Development Award from NIH, Dr. Wright served as president of the Orthopaedic Research Society in 1992. He is a former consulting editor for research of the Journal of Bone and Joint Surgery and is currently editor of the Journal of Orthopaedic Research.
Recently, Dr. Wright received a Director's Special Citation from the U.S. Food and Drug Administration for his work on a forum of academic, industry and agency representatives striving to improve the regulatory process for orthopedic devices.
Justin first joined HSS in the summer of 2012 and has since held various positions at the hospital across operations, strategy, business development, and service line management. Currently, as Vice President in the Executive Offices, Justin leads the hospital’s Service Line organization – overseeing strategy and operations for all major service lines including, but not limited to, the Department of Orthopedics and the Department of Medicine and Rheumatology. He also oversees HSS’s physician assistant department, helped establish and manage the hospital’s Value Management Office, and plays a significant role developing new markets, new channels, and new businesses for HSS.
Prior to joining HSS, Justin was a management consultant at the Monitor Group focusing predominately on growth strategy for pharmaceutical companies, payers, and medical device manufacturers. He also was the co-founder of EngagedHealth, a service-based startup that focused on lowering readmission rates for low-income patients with chronic conditions. Justin is currently a Mentor at Blueprint Health, a New York-based health technology accelerator.
Justin holds a BA in Political Economy and a Certificate in Finance from Princeton University, and an MBA with distinction from Harvard Business School.
Scott DeNegre, PhD
Assistant Vice President, Operational Excellence
Scott DeNegre, PhD, has several years of experience helping healthcare organizations manage their operational and strategic challenges and developing innovative solutions to increase efficiency, improve clinical outcomes, and enhance patient experience. During his tenure as the leader of Operational Excellence at HSS, he has worked on a variety of initiatives within the hospital, focusing most recently on Perioperative performance improvement.
Prior to joining HSS, Scott was a consultant with The Chartis Group, an advisory services firm that provides management consulting and applied research to leading healthcare organizations. In this role, he provided client support in the areas of enterprise strategic planning, capacity management, merger & acquisition planning, care coordination, cost and clinical performance improvement, and service line strategy.
Scott holds a BS in Mathematical Sciences from Johns Hopkins University, an MS in Management Science from Lehigh University, and a PhD in Industrial & Systems Engineering from Lehigh University.
Yukiji Fujimoto, PhD
Manager, Technology Development
Yukiji is a Manager for the Innovation and Technology Development team. She is responsible for the analysis, assessment and evaluation of commercial viability of technology; as well as, maintaining the HSS patent portfolio. In addition, Yukiji is managing the implementation of standard operating procedures and facilitating the integration of a knowledge management database.
Yukiji is a skilled research scientist with expertise in chemistry and glycobiology and has published a number of research papers in peer reviewed journals. She is applying her scientific knowledge in the business sector and as a person who has lived in New York her whole life; she is also committed to help make the New York metro region more successful in the bioscience industry.
Yukiji received her PhD in Chemistry with a specialty in Computational Biology from Stony Brook University and a BA concentrating in Chemistry and Art History from Sarah Lawrence College. In addition, she is an alumna of the Fundamentals of the Bioscience Industry program that is sponsored by the New York State Foundation for Science, Technology and Innovation (NYSTAR).
The extended innovation team provides critical interdisciplinary resources and support to the HSS Innovation Center. Members include leadership from several key departments including Research, Biomechanics, Biostatistics, Information Technology, Operations, Finance, Legal, Business Development, Strategy, Education, Nursing and Rehabilitation.